Small molecule inhibitors and CRISPR/Cas9 mutagenesis demonstrate that SMYD2 and SMYD3 activity are dispensable for autonomous cancer cell proliferation.
about
Small molecule inhibitors and CRISPR/Cas9 mutagenesis demonstrate that SMYD2 and SMYD3 activity are dispensable for autonomous cancer cell proliferation.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh-hant
name
Small molecule inhibitors and ...... ous cancer cell proliferation.
@en
Small molecule inhibitors and ...... ous cancer cell proliferation.
@nl
type
label
Small molecule inhibitors and ...... ous cancer cell proliferation.
@en
Small molecule inhibitors and ...... ous cancer cell proliferation.
@nl
prefLabel
Small molecule inhibitors and ...... ous cancer cell proliferation.
@en
Small molecule inhibitors and ...... ous cancer cell proliferation.
@nl
P2093
P2860
P1433
P1476
Small molecule inhibitors and ...... mous cancer cell proliferation
@en
P2093
Alejandra Raimondi
Alexandra R Grassian
Christina Majer
Christine Klaus
Cuyue Tang
Darren Harvey
Dorothy Brach
Elizabeth A Admirand
Haris Jahic
James E Mills
P2860
P304
P356
10.1371/JOURNAL.PONE.0197372
P407
P577
2018-06-01T00:00:00Z